Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 721

1.

Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.

Tiran V, Lindenmann J, Brcic L, Heitzer E, Stanzer S, Tabrizi-Wizsy NG, Stacher E, Stoeger H, Popper HH, Balic M, Dandachi N.

Sci Rep. 2017 Aug 30;7(1):10040. doi: 10.1038/s41598-017-09929-0.

2.

Rebuttal from Professor Helmut H. Popper.

Popper HH.

Transl Lung Cancer Res. 2017 Apr;6(2):243-245. doi: 10.21037/tlcr.2017.04.08. No abstract available.

3.

Cons: the confusing mucinous adenocarcinoma classification.

Popper HH.

Transl Lung Cancer Res. 2017 Apr;6(2):234-240. doi: 10.21037/tlcr.2017.04.09. No abstract available.

4.

Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.

Mairinger FD, Vollbrecht C, Flom E, Christoph DC, Schmid KW, Kollmeier J, Popper HH, Mairinger T, Walter RFH.

Oncotarget. 2017 Jun 6;8(23):37502-37510. doi: 10.18632/oncotarget.16398.

5.

[Interstitial processes of the lungs in childhood].

Popper H.

Pathologe. 2017 Jul;38(4):260-271. doi: 10.1007/s00292-017-0280-2. German.

PMID:
28349192
6.

Signal Transducer and Activator of Transcription 1 (STAT1) Knock-down Induces Apoptosis in Malignant Pleural Mesothelioma.

Arzt L, Halbwedl I, Gogg-Kamerer M, Popper HH.

Pathol Oncol Res. 2017 Jul;23(3):595-605. doi: 10.1007/s12253-016-0157-3. Epub 2016 Dec 16.

PMID:
27987139
7.

Commentary on tumor heterogeneity.

Popper HH.

Transl Lung Cancer Res. 2016 Aug;5(4):433-5. doi: 10.21037/tlcr.2016.08.07. No abstract available.

8.

Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).

Geltner C, Errhalt P, Baumgartner B, Ambrosch G, Machan B, Eckmayr J, Klikovits T, Hoda MA, Popper H, Klepetko W; Austrian Mesothelioma Interest Group (AMIG).

Wien Klin Wochenschr. 2016 Sep;128(17-18):611-7. doi: 10.1007/s00508-016-1080-z. Epub 2016 Sep 12.

9.

Pathology of Asbestosis: An Update of the Diagnostic Criteria Response to a Critique.

Roggli V, Gibbs AR, Attanoos R, Churg A, Popper H, Corrin B, Franks T, Galateau-Salle F, Galvin J, Hasleton P, Honma K.

Arch Pathol Lab Med. 2016 Sep;140(9):950-2. doi: 10.5858/arpa.2015-0503-SA. No abstract available.

PMID:
27575267
10.

Pathologists and liquid biopsies: to be or not to be?

Hofman P, Popper HH.

Virchows Arch. 2016 Dec;469(6):601-609. Epub 2016 Aug 23. Review.

PMID:
27553354
11.

[Neuroendocrine neoplasms of the mediastinum].

Brcic L, Heidinger M, Popper H.

Pathologe. 2016 Sep;37(5):434-40. doi: 10.1007/s00292-016-0198-0. Review. German.

PMID:
27507161
12.

RANKL/RANK control Brca1 mutation-driven mammary tumors.

Sigl V, Owusu-Boaitey K, Joshi PA, Kavirayani A, Wirnsberger G, Novatchkova M, Kozieradzki I, Schramek D, Edokobi N, Hersl J, Sampson A, Odai-Afotey A, Lazaro C, Gonzalez-Suarez E, Pujana MA, Cimba F, Heyn H, Vidal E, Cruickshank J, Berman H, Sarao R, Ticevic M, Uribesalgo I, Tortola L, Rao S, Tan Y, Pfeiler G, Lee EY, Bago-Horvath Z, Kenner L, Popper H, Singer C, Khokha R, Jones LP, Penninger JM.

Cell Res. 2016 Jul;26(7):761-74. doi: 10.1038/cr.2016.69. Epub 2016 May 31.

13.

Loss of adipose triglyceride lipase is associated with human cancer and induces mouse pulmonary neoplasia.

Al-Zoughbi W, Pichler M, Gorkiewicz G, Guertl-Lackner B, Haybaeck J, Jahn SW, Lackner C, Liegl-Atzwanger B, Popper H, Schauer S, Nusshold E, Kindt AS, Trajanoski Z, Speicher MR, Haemmerle G, Zimmermann R, Zechner R, Vesely PW, Hoefler G.

Oncotarget. 2016 Jun 7;7(23):33832-40. doi: 10.18632/oncotarget.9418.

14.

Progression and metastasis of lung cancer.

Popper HH.

Cancer Metastasis Rev. 2016 Mar;35(1):75-91. doi: 10.1007/s10555-016-9618-0. Review.

15.

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.

Brambilla E, Le Teuff G, Marguet S, Lantuejoul S, Dunant A, Graziano S, Pirker R, Douillard JY, Le Chevalier T, Filipits M, Rosell R, Kratzke R, Popper H, Soria JC, Shepherd FA, Seymour L, Tsao MS.

J Clin Oncol. 2016 Apr 10;34(11):1223-30. doi: 10.1200/JCO.2015.63.0970. Epub 2016 Feb 1.

16.

Clinical Manifestations of Respiratory Bronchiolitis as an Incidental Finding in Surgical Lung Biopsies: A Retrospective Analysis of a Large Austrian Registry.

Scheidl SJ, Kusej M, Flick H, Stacher E, Matzi V, Kovacs G, Popper HH, Costabel U, Olschewski H.

Respiration. 2016;91(1):26-33. doi: 10.1159/000442053. Epub 2015 Dec 12.

17.

Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival.

Geles A, Gruber-Moesenbacher U, Quehenberger F, Manzl C, Al Effah M, Grygar E, Juettner-Smolle F, Popper HH.

Virchows Arch. 2015 Dec;467(6):675-686. Epub 2015 Oct 8.

PMID:
26450556
18.

Old dilemma: asthma with irreversible airway obstruction or COPD.

Fattahi F, Vonk JM, Bulkmans N, Fleischeuer R, Gouw A, Grünberg K, Mauad T, Popper H, Felipe-Silva A, Vrugt B, Wright JL, Yang HM, Kocks JW, Hylkema MN, Postma DS, Timens W, Ten Hacken NH.

Virchows Arch. 2015 Nov;467(5):583-93. doi: 10.1007/s00428-015-1824-6. Epub 2015 Sep 14.

19.

Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe: The INSIGHT Study.

Ramlau R, Cufer T, Berzinec P, Dziadziuszko R, Olszewski W, Popper H, Bajcic P, Dusšk L, Zbozinkova Z, Pirker R; INSIGHT study team.

J Thorac Oncol. 2015 Sep;10(9):1370-1374. doi: 10.1097/JTO.0000000000000621.

20.

[Pulmonary Langerhans cell histiocytosis].

Popper HH.

Pathologe. 2015 Sep;36(5):451-7. doi: 10.1007/s00292-015-0052-9. Review. German.

PMID:
26289803

Supplemental Content

Loading ...
Support Center